Ajinomoto Co Inc
TSE:2802
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (13.9), the stock would be worth ¥2 733.84 (41% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 23.7 | ¥4 658 |
0%
|
| 3-Year Average | 13.9 | ¥2 733.84 |
-41%
|
| 5-Year Average | 13.4 | ¥2 629.4 |
-44%
|
| Industry Average | 8.2 | ¥1 603.52 |
-66%
|
| Country Average | 8.7 | ¥1 703.98 |
-63%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥5.1T
|
/ |
Jan 2026
¥202.4B
|
= |
|
|
¥5.1T
|
/ |
Mar 2026
¥281.1B
|
= |
|
|
¥5.1T
|
/ |
Mar 2027
¥305B
|
= |
|
|
¥5.1T
|
/ |
Mar 2028
¥338.4B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Ajinomoto Co Inc
TSE:2802
|
4.5T JPY | 23.7 | 57.9 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 186 542.5 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
193.8B CHF | 13.3 | 21.5 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
71.8B USD | 17.9 | 29.3 | |
| FR |
|
Danone SA
PAR:BN
|
43.5B EUR | 9.8 | 24 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
49.6B ZAR | 9.6 | 13 | |
| US |
|
Hershey Co
NYSE:HSY
|
38.3B USD | 21.1 | 43.3 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
244.3B CNY | 15.3 | 15.4 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
232.6B CNY | 24.8 | 33 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.8B ZAR | 8.9 | 13.1 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.6B CHF | 19 | 32 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
Ajinomoto Co Inc
Glance View
Ajinomoto Co., Inc., a household name synonymous with umami, has woven a rich tapestry in the fabric of the global food industry. Originally starting its journey in 1908, the company was founded by Dr. Kikunae Ikeda, who isolated and identified the flavor-enhancing properties of monosodium glutamate (MSG). It began its commercial journey by marketing this unique seasoning under the brand name "Ajinomoto," which translates to "essence of taste" in Japanese. Building upon this foundation, Ajinomoto has expanded far beyond MSG, leveraging its biochemical prowess to create a diverse range of food products and ingredients. This transition from a single product line to a multitude of culinary offerings has established Ajinomoto as a global leader in the food industry, catering to numerous markets with products that enhance the flavors of everyday meals. More than just a staple in pantries worldwide, Ajinomoto delves into the scientific realm of food and health. Its business model capitalizes not only on traditional seasoning products but also on innovative solutions in amino acids and wellness markets. The company generates revenue by harnessing biotechnologies to produce amino acids for pharmaceuticals, nutritional supplements, and the burgeoning wellness industry. Ajinomoto combines its biochemical expertise with a deep understanding of consumer trends to develop novel products that align with health and sustainability. Its strategic investments in technology and research empower the company to navigate contemporary challenges, ensuring its relevance and growth in an evolving marketplace. Through this dual focus on taste and health, Ajinomoto maintains its charismatic presence from bustling markets in Japan to homes across the globe.